Metropolis Healthcare Ltd Share Price Today - Metropolis Healthcare Ltd Stock Price Live NSE/BSE

Metropolis Healthcare Ltd

NSE: METROPOLIS BSE: 542650

₹549.50

(8.68%)

Tue, 19 May 2026, 11:31 am

MTF 5xInvest in Metropolis Healthcare Ltd with 5x Leverage Buy with MTF

Market Cap114.09B

PE Ratio67.93

Dividend0.18

Health Services

Medical/Nursing Services

24.5K

Metropolis Healthcare Share Price Live Chart

1 Day

(8.68%)

No Result Found

Summary

Market Cap
10527.28
Net Profit
145.51
P/B
6.12
Sector P/E
61.44
P/E
55.83
EV/EBITDA
25.51
Debt/Equity (Industry)
0.18
Interest Cover (Industry)
12.19
ROCE (Industry)
17.69
RONW (Industry)
14.86
ROE
11.99
ROCE
14.96
Debt/Equity
0.17
EPS (TTM)
9.48
Dividend Yield
0
Book Value
72.98
Interest Cover
8.99

Analysis

all

Pros

Dividends paid are well covered by earnings (3.2x coverage).
Dividends after 3 years are expected to be covered by earnings (1.8x coverage).
Metropolis Healthcare's earnings are expected to grow significantly at over 20% yearly.
Metropolis Healthcare's earnings growth is expected to exceed the India market average.
Metropolis Healthcare's earnings growth is expected to exceed the low risk savings rate of 7.2%.

Cons

Metropolis Healthcare only just started paying a dividend, it is too early to tell if payments are increasing.
It is too early to tell whether Metropolis Healthcare has stable dividend payments.
Metropolis Healthcare's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
Metropolis Healthcare's dividend is below the markets top 25% of dividend payers in India (3.08%).
Cash flow for Metropolis Healthcare is expected to increase but not above the 50% threshold in 2 years time.

Financials

Ratios

Shareholders	MAR 2026	DEC 2025	SEPT 2025	JUN 2025	MAR 2025
Promoters	48.87	48.88	48.89	48.89	48.90
FII	10.43	11.69	12.52	12.83	15.29
DII	35.79	34.73	33.10	32.40	30.30
Public	4.91	4.71	5.49	5.88	5.52
Government	0	0	0	0	0

Technical Analysis

RSI

52.92

MACD

16.31

50 DMA

473.53

200 DMA

490.28

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	625.35	543.20	509.85	461.05	427.70	378.90	296.75
Fibonacci	543.20	511.82	492.43	461.05	429.67	410.28	378.90
Camarilla	499.09	491.56	484.03	461.05	468.97	461.44	453.91

Pivots Level: Classic

+164.30

625.35

+82.15

543.20

+48.80

509.85

461.05

Pivot Point

LTP: 508.40

-33.35

427.70

-82.15

378.90

-164.30

296.75

Moving Average

SMAEMA

Period

Value

10-EMA
520.85
20-EMA
508.77
30-EMA
498.96
50-EMA
488.52
100-EMA
481.85
200-EMA
479.41

Announcement Date	Purpose	Action	Ex Date
13 May 2026	dividend	₹1.00 Dividend /Share	19 May 2026
13 May 2026	board-meetings	Accounts, Interim Dividend
11 Mar 2026	bonus	3:1 Bonus Issue of Equity Shares	20 Mar 2026
04 Feb 2026	board-meetings	Quarterly Results
04 Nov 2025	dividend	₹4.00 Dividend /Share	11 Nov 2025
04 Nov 2025	board-meetings	Quarterly Results, Interim Dividend
11 Oct 2025	dividend	Interim Dividend - Rs. - 4	11 Nov 2025
22 Jul 2025	agm
31 Jul 2024	agm
04 Nov 2023	dividend	₹4.00 Dividend /Share	17 Nov 2023

Metropolis Healthcare Ltd

Fortis Healthcare Ltd

Apollo Hospitals Enterprise Ltd

Max Healthcare Institute Ltd

Aster DM Healthcare Ltd

Narayana Hrudayalaya Ltd

Metropolis Healthcare Ltd About

Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services.

Industry

Healthcare

Founded

2000

Headquarters

CEO

Ameera Sushil Shah

Employees

Contact

Website

http://www.metropolisindia.com

investor.relations@metropolisindia.com

Phone

91-22-62582810

Location

250 D Udyog Bhavan, Worli, Mumbai, Maharashtra, 400030

Year	History
2017	Metropolis Healthcare acquired Sanjeevani Pathology Laboratory in Rajkot.
2018	Metropolis Healthcare executed a Public-Private partnership agreement with the National AIDS Control Organisation, Government of India. Metropolis Healthcare implemented the Scheme of Amalgamation 2018. Metropolis Healthcare incorporated a subsidiary in Tanzania. Metropolis Healthcare was awarded for 'Best in Health and Fitness' in the Digital Campaign Awards by LH Insights. Metropolis Healthcare was awarded for 'Excellence in Customer Service & Delivery' by Biotrains. Metropolis Healthcare received a special jury mention for 'Service Excellence (Diagnostic Centre)' by FICCI at the Healthcare Excellence Awards.
2020	Metropolis Healthcare won the India CSR award for the 'Too Shy To Ask' App. Metropolis Healthcare was awarded India Diagnostic Service Provider Company of the year 2020.
2021	Metropolis Healthcare completed the acquisition of Hitech Diagnostic Centre. Metropolis Healthcare's Board of Directors approved the acquisition of Dr. Ganesan's Hitech Diagnostic Centre.
2024	Metropolis Healthcare Limited completed the acquisition of Metropolis Foundation. Metropolis Healthcare Limited acquired a 100% stake in Core Diagnostics Private Limited.

Client Name	Deal Type	Order Side	QTY	Avg Price	Date
CORE DIAGNOSTICS (MAURITIUS) PRIVATE LIMITED	bulk	Sell	292457	1905.11	04 Dec 2025
GOLDMAN SACHS (SINGAPORE) PTE.- ODI	block	Sell	55000	1944	16 Oct 2025
GOLDMAN SACHS BANK EUROPESE - ODI	block	Buy	55000	1944	16 Oct 2025
GRAVITON RESEARCH CAPITAL LLP	bulk	Buy	259625	1690.38	21 Dec 2023
GRAVITON RESEARCH CAPITAL LLP	bulk	Sell	280825	1683.49	21 Dec 2023
GRANDEUR PEAK GLOBAL REACH FUND	block	Sell	38641	1509.95	20 Oct 2023
GRANDEUR PEAK EMERGING MARKETS OPPORTUNITIES FUND	block	Sell	275352	1509.95	20 Oct 2023
GRANDEUR PEAK GLOBAL MICRO CAP FUND	block	Sell	19428	1509.95	20 Oct 2023
GRANDEUR PEAK GLOBAL TRUST GRANDEUR PEAK GLOBAL OPPORTUNITIES FUND	block	Buy	157620	1509.95	20 Oct 2023
GRANDEUR PEAK GLOBL TRUST GP EMERGING MARKETS OPPORTUNITIES FUND	bulk	Buy	275352	1509.95	20 Oct 2023

Metropolis Healthcare Ltd News

Metropolis Healthcare Q4FY26 Earnings Call Audio Available

Metropolis Healthcare confirms audio recording of Q4FY26 earnings conference call held on May 14, 2026 at 9:00 am IST is now available on the company's website.

15 May 2026

companies

Metropolis Healthcare Q4FY26 Earnings Call Audio Now Available

Metropolis Healthcare's Q4FY26 earnings conference call held on May 14, 2026 at 9:00 am IST; audio recording now available on the company's website.

14 May 2026

companies

Metropolis Healthcare Sets 13-15% Growth Target for FY27

Metropolis Healthcare targets 13-15% growth for FY27. Q4FY26 revenue rose 23% YoY to INR 425 Cr, EBITDA surged 71% to INR 108 Cr, PAT up 75% to INR 51 Cr.

14 May 2026

companies

Metropolis Healthcare Q4FY26: Revenue Up 23%, Network Tops 5,000 Centres

Metropolis Healthcare Q4FY26 revenue grew 23% YoY to INR 425 Cr, EBITDA surged 71% YoY to INR 108 Cr, PAT rose 75% YoY to INR 51 Cr, crossing 5,000+ centres milestone.

13 May 2026

companies

Metropolis Healthcare Q4FY26: EBITDA Up 71%, PAT Rises 75% YoY

Metropolis Healthcare reported Q4FY26 revenue of INR 425 Cr (+23% YoY), EBITDA of INR 108 Cr (+71% YoY), and PAT of INR 51 Cr (+75% YoY), crossing 5,000+ centres milestone.

13 May 2026

companies

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800